NYMOX PHARMACEUTICAL CORPORATION Other Income
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Other Income of $0 for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Income Statement › Other Income
ifrs-full:OtherIncome · last filed 2025-06-03
- NYMOX PHARMACEUTICAL CORPORATION other income for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION other income for the quarter ending 2022-12-31 was -$3.00M.
- NYMOX PHARMACEUTICAL CORPORATION other income for the quarter ending 2022-09-30 was $0.00.
- NYMOX PHARMACEUTICAL CORPORATION other income for the quarter ending 2022-06-30 was $3.12M.
| Period end | Other Income 3 month | Other Income 6 month | Other Income 9 month | Other Income 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 20-F · filed 2025-06-03 | |||
| 2023-12-31 | $0.00 20-F · filed 2025-06-03 | |||
| 2023-06-30 | $0.00 6-K · filed 2023-08-14 | $0.00 6-K · filed 2023-08-14 | ||
| 2022-12-31 | -$3.00M derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | -$3.00M derived: sum of 2 quarters · filed 2025-06-03 | $113.00K derived: sum of 3 quarters · filed 2025-06-03 | $113.00K 20-F · filed 2025-06-03 |
| 2022-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2023-11-15 | $3.12M derived: sum of 2 quarters · filed 2023-11-15 | $3.12M 6-K · filed 2023-11-15 | |
| 2022-06-30 | $3.12M 6-K · filed 2023-08-14 | $3.12M 6-K · filed 2023-08-14 | ||
| 2021-12-31 | $0.00 20-F · filed 2024-08-29 | |||
| 2020-12-31 | $0.00 20-F · filed 2023-05-02 |